Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propensity Score Analysis.

Published in:

Gastroenterology Research & Practice, 2018, p. 1, doi. 10.1155/2018/2373868

By:

• Ventriglia, J.;
• Petrillo, A.;
• Huerta Alváro, M.;
• Laterza, M. M.;
• Savastano, B.;
• Gambardella, V.;
• Tirino, G.;
• Pompella, L.;
• Diana, A.;
• Iovino, F.;
• Troiani, T.;
• Martinelli, E.;
• Morgillo, F.;
• Orditura, M.;
• Cervantes, A.;
• Ciardiello, F.;
• De Vita, F.

Publication type:

Article